Moderna's coronavirus vaccine business will lose steam in the next 12 months.
The company is looking at steady progress with its pipeline.
Although the short-term is unpredictable, Moderna's long-term prospects look attractive.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,